Coronavirus outbreak: Vaccine in very early stages of development

Published: 
Xinhua
Listen to this article

A report states that the Chinese Centre for Disease Control is testing an mRNA vaccine candidate on mice

Xinhua |
Published: 
Comment

Latest Articles

Companion dogs comfort Hong Kong’s seniors through new programme

Taylor Swift’s storytelling shines in The Tortured Poets Department

Glowing animals go much further back in time than we thought

SOTY 2022/23: Art runs in the family for Visual Artist second runner-up

SOTY 2022/23: Linguist (English) first runner-up loves to play devil’s advocate

Hong Kong children are taller and heavier over the last 30 years

A vaccine for the coronavirus Covid-19 in is the very early stages of development, a report by Xinhua states.

A candidate vaccine targeting Covid-19 has been tested on animals, according to a report published last week on news portal yicai.com, citing sources with the Chinese Centre for Disease Control and Prevention (CDC).

The vaccine, which targets messenger RNA (mRNA) in the virus, was co-developed by the CDC, Shanghai-based Tongji University School of Medicine and Stermirna Therapeutics Co., Ltd. The vaccine samples were injected into more than 100 mice Sunday, the report said. This came just two weeks after the centre successfully isolated the first new coronavirus strain on January 24.

A CDC official warned that the animal testing was at a very early stage of vaccine development and there were still many steps to be taken before the vaccine is ready to be used on humans.

Lesson plan: How our immune system fights off the coronavirus and other diseases

Testing on mice was only an initial screening of a candidate vaccine. After that there would be toxicity tests on larger animals such as monkeys to ensure the safety of the vaccine in human clinical trials, said the report, citing a researcher of Tongji University.

The development and production cycle of the mRNA vaccine is shorter than that of traditional vaccines. A number of research institutes and companies around the world are stepping up efforts to develop vaccines and agents against the novel coronavirus spreading around the world, which has already exceeded the death toll from the global outbreak of SARS that started in China almost two decades ago.

Sign up for the YP Teachers Newsletter
Get updates for teachers sent directly to your inbox
By registering, you agree to our T&C and Privacy Policy
Comment